(Q40729476)

23 September 2017

title

Adeno-associated virus-mediated gene transfer of endostatin inhibits angiogenesis and tumor growth in vivo (English)

1 reference

23 September 2017

Wenyin Shi

1

0 references

author name string

Christian Teschendorf

series ordinal

2

1 reference

23 September 2017

Nicholas Muzyczka

series ordinal

3

1 reference

23 September 2017

Dietmar W Siemann

series ordinal

4

1 reference

23 September 2017

publication date

1 June 2002

1 reference

23 September 2017

1 reference

23 September 2017

volume

9

1 reference

23 September 2017

issue

6

1 reference

23 September 2017

page(s)

513-521

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.cgt.7700463

23 September 2017

exact match

0 references

cites work

Angiogenesis in cancer, vascular, rheumatoid and other disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700463

Tumor angiogenesis correlates with lymph node metastases in invasive bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700463

The scope of the problem of primary tumor control

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700463

Inhibition of tumor angiogenesis as a strategy to circumvent acquired resistance to anti-cancer therapeutic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700463

Angiogenic attack as a therapeutic strategy for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700463

Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700463

Endostatin: an endogenous inhibitor of angiogenesis and tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700463

Effects of angiogenesis inhibitors on multistage carcinogenesis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700463

Endostatin "cell factories" shrink rodent brain tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700463

Adenovirus-mediated gene transfer of endostatin in vivo results in high level of transgene expression and inhibition of tumor growth and metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700463

Administration of helper-dependent adenoviral vectors and sequential delivery of different vector serotype for long-term liver-directed gene transfer in baboons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700463

AAV as a viral vector for human gene therapy. Generation of recombinant virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700463

Long-term correction of obesity and diabetes in genetically obese mice by a single intramuscular injection of recombinant adeno-associated virus encoding mouse leptin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700463

Long-term gene transfer to mouse fetuses with recombinant adenovirus and adeno-associated virus (AAV) vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700463

Long-term in vivo cochlear transgene expression mediated by recombinant adeno-associated virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700463

Progress in adeno-associated virus type 2 vector production: promises and prospects for clinical use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700463

Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700463

Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700463

Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700463

Cloning, expression, and in vitro activity of human endostatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700463

Zinc-dependent dimers observed in crystals of human endostatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700463

Systemic inhibition of tumor growth and tumor metastases by intramuscular administration of the endostatin gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700463

Adenovirus-mediated delivery of antiangiogenic genes as an antitumor approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700463

Antiangiogenic gene therapy for cancer via systemic administration of adenoviral vectors expressing secretable endostatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700463

Immune responses to transgene-encoded proteins limit the stability of gene expression after injection of replication-defective adenovirus vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700463

Factors influencing the development of an anti-factor IX (FIX) immune response following administration of adeno-associated virus-FIX.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700463

Adenovirus and adeno-associated virus as vectors for gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700463

Stable gene transfer and expression of human blood coagulation factor IX after intramuscular injection of recombinant adeno-associated virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700463

Recombinant adeno-associated virus for muscle directed gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700463

Long-term correction of canine hemophilia B by gene transfer of blood coagulation factor IX mediated by adeno-associated viral vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700463

Adenovirus-mediated human endostatin gene delivery demonstrates strain-specific antitumor activity and acute dose-dependent toxicity in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700463

Quantitation and prognostic value of breast cancer angiogenesis: Comparison of microvessel density, Chalkley count, and computer image analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700463

Endostatin induces endothelial cell apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700463

7 January 2021

Adeno-associated virus and other potential vectors for angiostatin and endostatin gene therapy.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700463

7 January 2021

Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700463

7 January 2021

Intra-tumoral administration of naked plasmid DNA encoding mouse endostatin inhibits renal carcinoma growth

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700463

7 January 2021

Transduction of dendritic cells by DNA viral vectors directs the immune response to transgene products in muscle fibers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700463

7 January 2021

Cytotoxic T-lymphocyte target proteins and their major histocompatibility complex class I restriction in response to adenovirus vectors delivered to mouse liver.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700463

7 January 2021

Identifiers

DOI

10.1038/SJ.CGT.7700463

1 reference

Dimensions Publication ID

23 September 2017

1036125774

0 references

1 reference